New genetically engineered herpes virus kills cancer cells

Although the treatment is still in early trials, researchers have found that RP2, a modified version of the herpes simplex virus, managed to kill cancer cells in a quarter of patients.

“Our initial trial findings suggest that a genetically engineered form of the herpes virus could potentially become a new treatment option for some patients with advanced cancers – including those who haven’t responded to other forms of immunotherapy,” Harrington explained.The herpes virus has been modified to serve as a cure.The newly-engineered RP2 virus is injected directly into the tumors where it functions in two ways.

Finally, RP2 has also been modified to produce molecules called GM-CSF and GALV-GP-R, which give the virus additional capabilities to spark the immune system into action against cancer.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Lung Cancer: Early Signs, Symptoms, StagesLearn about lung cancer early warning signs, symptoms and treatments. What causes stage IV lung cancer? Get more information on small cell lung cancer, non-small cell lung cancer, and the diagnosis of lung cancer stages.
Source: MedicineNet - 🏆 575. / 51 Read more »